CD44 and cancer: Additionally, differential expression of RNA-seq comparing the resistant and the sensitive groups revealed distinct genetic signatures corresponding to resistance and sensitivity, with upregulation of ITGA3 and CD44, an extracellular matrix marker of cancer stemness (Fig. 3B; refs. 29–31).